All drug acquisition operations are carried out exclusively within the framework of the law. Contracts are previously published on the national public procurement portal and are subject to strict control. The potassium supply contract was awarded to a local manufacturing company through a rigorous tender process, not to an importing company with a temporary authorization. Public contracts are never concluded with individuals, but with companies governed by commercial law. The production of sodium chloride by Promopharm significantly decreased between 2023 and 2025. The number of exceptional import authorizations increased in 2024 before decreasing in 2025.